N6-methyladenosine modification as an mRNA modification
in mammalian
cells is dynamically reversible, regulated by RNA demethylase [e.g.,
fat mass and obesity-associated protein (FTO)]. The abnormal expression
of FTO is closely related to numerous diseases (e.g., various cancers
and obesity). Herein, we demonstrate the single-molecule counting
of FTO in human cancer cells and breast tissues based on a T7 RNA
polymerase-mediated rolling circle transcription (RCT) amplification-driven
clustered regularly interspaced short palindromic repeat (CRISPR)Cas12a.
When FTO is present, it demethylates the DNA substrate, initiating
the DpnII-mediated cleavage reaction. After magnetic separation, the
cleaved DNA fragments trigger the T7 RNA polymerase-mediated RCT amplification,
activating CRISPR-/Cas12a-mediated cleavage of signal probes and releasing
abundant FAM molecules that are simply counted via single-molecule
detection. In this assay, only target FTO can generate CRISPR RNAs,
efficiently improving detection specificity. Moreover, the integration
of single-molecule detection with magnetic separation achieves zero
background and effectively enhances detection sensitivity. This method
can specifically and sensitively monitor FTO activity with a limit
of detection of 1.20 × 10–13 M, and it may
measure FTO at the single-cell level. Furthermore, it may accurately
discriminate the FTO expression level in breast tissues between healthy
persons and breast cancer patients and screen the FTO inhibitors as
well, with great potential in clinical diagnosis and drug discovery.